CbusineZ

What CbusineZ does

CbusineZ is a Dutch healthcare innovation and participation fund organized as a stichting (foundation), established in 2000 by health insurer CZ and formally incorporated as an independent entity in 2001. Headquartered in Tilburg, the organization operates as a revolving fund (revolverend fonds) that invests in early-stage healthcare ventures across the Netherlands, deploying initial tickets typically ranging from €100,000 to €500,000 and reinvesting any returns back into healthcare innovation rather than distributing profit. Its core methodology is the proprietary CbusineZ Venture Management (CVM) framework, a 13-dimension assessment tool used to evaluate market exploration, solution validation, team quality, and business plan robustness across pre-seed to Series A opportunities.

The fund manages a portfolio of 25+ active ventures organized around five strategic themes: Appropriate Care, Digital Self-Care, Smart Organization, Data Exchange, and Processes. Portfolio companies span digital health platforms (QurioCare, Psylaris, ikHerstel), medical devices (MS sherpa, Angiogenesis Analytics), ML-based clinical decision support (Pacmed), ambulance dispatch optimization (Stokhos), and staffing solutions (Freddify, Human Total Care). Beyond capital, CbusineZ actively coaches leadership teams, facilitates ecosystem introductions across the Dutch healthcare system, and incubates new ventures. In 2025 the organization published the Zorginnovatieagenda — a strategic roadmap of 10 missions for Dutch healthcare transformation — and has co-founded specialized vehicles including IFOZ for elderly care.

Revenue mechanics are non-commercial: CbusineZ generates no traditional revenue. Capital flows originate from its founding sponsor CZ, co-investment partners (Borski Fund, NextGen Ventures, Brabant Development Agency, Invest-NL), EU procurement contracts (€8.85M via HaDEA/DG HERA channeled through portfolio companies like ShanX Medtech), and recycled returns from successful exits. The organization employs 11–50 staff, sources deals exclusively through network relationships within the Dutch healthcare ecosystem, and maintains operational independence from CZ while retaining strategic alignment through governance overlap (CZ management board member serving as Supervisory Board chairman).

Name

CbusineZ

Legal name

CbusineZ

Website

https://cbusinez.nl

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

CbusineZ is a Dutch healthcare foundation and revolving fund, founded in 2000 by CZ health insurer, that invests €100K–€500K in early-stage Dutch healthcare ventures across five thematic areas, manages a portfolio of 25+ companies, and reinvests returns into further innovation.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (523940), Pension Funds (52511)

SIC

Investment Advice (6282), Finance Services (6199)

akta.pro industry

PRIMARYFSANAHAB

Captive CVC Fund (Dedicated corporate fund structure)

Financial & Insurance/Private Equity & Venture Capital/Corporate Venture Capital (CVC)

SECONDARYFSANAHAA

Strategic / Balance-Sheet CVC (On-balance-sheet investing)

Financial & Insurance/Private Equity & Venture Capital/Corporate Venture Capital (CVC)

SECONDARYFSANAHAF

Corporate Strategic Partnership & Ecosystem Investment Arms

Financial & Insurance/Private Equity & Venture Capital/Corporate Venture Capital (CVC)

Keywords

• Healthcare venture capital
• Early-stage investment fund
• Medical startup incubation
• Healthcare innovation fund
• Revolving fund healthcare

Headquarters

HQ city

Tilburg

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Revolving Fund Returns: CbusineZ operates as a revolving fund (revolverend fonds) that reinvests any profits and returns into new healthcare innovations. The fund was established by CZ health insurer and is not commercially driven - returns are cycled back into the healthcare ecosystem rather than distributed as profit.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

CbusineZ is a Dutch healthcare innovation and participation fund (stichting) that invests in and incubates early-stage healthcare ventures across five strategic themes: Appropriate Care, Digital Self-Care, Smart Organization, Data Exchange, and Processes. Using its proprietary CbusineZ Venture Management (CVM) method, it deploys initial investments typically ranging from €100,000 to €500,000, while providing active coaching to leadership teams and ecosystem access across Dutch healthcare providers and institutions. The fund operates as a revolving vehicle, reinvesting returns back into healthcare innovation rather than distributing profit.

Product overview

CbusineZ is a healthcare innovation and participation fund (stichting) that operates as a non-commercially-driven revolving investment vehicle focused on transforming Dutch healthcare. Rather than a unified software product, CbusineZ offers venture investment and incubation services, deploying its proprietary CVM (CbusineZ Venture Management) method to identify and support early-stage healthcare ventures. The organization manages a portfolio of over 25 active ventures across five strategic healthcare themes (Appropriate Care, Digital Self-Care, Smart Organization, Data Exchange, and Processes), with investments ranging from €100,000 to €500,000 per initial round. Key portfolio companies include Pacmed (ML-based clinical decision support), Stokhos (ambulance optimization algorithms), Psylaris (mental health software), and ikHerstel (post-surgery e-health). In late 2025, CbusineZ launched its Zorginnovatieagenda, a strategic roadmap with 10 missions for healthcare transformation. The organization also co-founded IFOZ, a dedicated elderly care innovation fund.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Investment & Incubation Program Core investment and incubation offering for early-stage Dutch healthcare ventures, providing initial investments typically ranging from €100,000 to €500,000 alongside active coaching and ecosystem support through the CVM method.
• CbusineZ Venture Management (CVM) Method Proprietary venture assessment methodology evaluating prospective investments across 13 dimensions including market exploration, solution validation, entrepreneurship quality, team strength, and business plan robustness.
• Healthcare Innovation Themes (Five Focus Areas) Five thematic investment focus areas guiding portfolio construction: Appropriate Care (Passende zorg), Digital Self-Care (Digitale zelfzorg), Smart Organization (Slim organiseren), Data Exchange (Data-uitwisseling), and Processes (Processen). Targets ventures that free up healthcare capacity, redirect demand, or avoid costs.
• Portfolio Ventures (25+ active healthcare companies) Active portfolio of 25+ Dutch healthcare ventures including digital health platforms (QurioCare, Psylaris, ikHerstel), medical devices (MS sherpa, Angiogenesis Analytics), decision support software (Pacmed, PATIENT+), operational optimization (Stokhos, VECOZO, ZorgMatch), and staffing solutions (Freddify, Human Total Care).
• Innovatiefonds Ouderenzorg (IFOZ) Dedicated innovation fund for elderly care, co-founded by CbusineZ together with four progressive care organizations, supporting initiatives that contribute to independence at home or labor savings in elderly care.

Quantifiable outcome

• Portfolio of 25+ healthcare ventures supported

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Partnerships

One partnership is on record.

• TU EindhovensupportingStrategic or Co-development PartnerAcademic partnership providing research collaboration and access to innovation from university ecosystem.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Others

• EIT Health: European public-private partnership co-funded by the EU that supports healthcare innovation across Europe. Comparable as an EU-backed ecosystem actor providing capital, grants, and programs to healthcare startups, with thematic overlap to CbusineZ's healthcare innovation mission and access to similar HaDEA-funded programs.

Emerging players

• Inkef Capital: Dutch venture capital firm with healthcare and technology focus. Comparable as a Netherlands-rooted VC investing in European early-stage ventures, with overlapping exposure to healthcare and digital health themes.
• Apollo Ventures (Healthspan Capital): European early-stage venture fund focused on aging and healthspan, based in Copenhagen. Comparable as a thematic healthcare investor with a mission-driven mandate overlapping with CbusineZ's elderly-care focus (e.g., IFOZ), though operating in Northern Europe rather than the Netherlands.

Direct peers

• NextGen Ventures: Dutch early-stage VC co-investing with CbusineZ in healthcare innovation. Comparable as a Netherlands-based venture investor with overlap in healthcare and technology-enabled services at pre-seed to seed stage.
• Borski Fund: Dutch impact-focused VC that led the ShanX Medtech seed round and frequently co-invests with CbusineZ. Comparable as a Dutch venture investor backing early-stage companies with mission alignment, particularly in health and sustainability.
• Brabantse Ontwikkelings Maatschappij (BOM): Regional Dutch development agency and active co-investor with CbusineZ in healthcare ventures. Directly comparable as a Dutch public investor deploying venture and growth capital into innovative companies, including healthcare, with a similar regional economic-development lens.

Broad incumbents

• Philips Health Technology Ventures: Corporate venture arm of Philips, a global health technology company, investing in adjacent digital health and medical technology. Comparable as a large corporate-backed CVC operating in Dutch and global healthcare innovation, though at materially larger scale and broader mandate.
• Invest-NL: Dutch national development finance institution that co-invested alongside CbusineZ in the ShanX Medtech €15M seed round. Comparable as a mission-driven, government-backed investor in Dutch innovation with healthcare exposure, but with a much broader mandate beyond healthcare.

Regional players

• LSP (Life Sciences Partners): European healthcare and life sciences-focused venture capital firm headquartered in the Netherlands. Comparable as a Dutch-rooted VC investing in European healthcare innovation, but with a more traditional VC structure and broader European footprint.
• Novo Holdings (Novo Seeds): Denmark-based holding company of the Novo Nordisk Foundation, with a major healthcare and biotech venture investment arm. Comparable as a mission-aligned, foundation-backed healthcare investor, though at much larger scale and with a Nordic rather than Dutch geographic focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cbusinez

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CbusineZ